EGFR and cancer: Although it will be important in future studies to assess the precise underlying mechanisms by which TRPV1 regulates autophagy-dependent EGFR activation, this connection immediately hints at several potentially promising therapeutic targets to control cisplatin-resistant cancer in the clinic.